‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year

Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy changes by the Trump administration

• Get our breaking news email, free app or daily news podcast

A “life-saving” drug heavily subsidised for Australians living with opioid dependency will be pulled from the market by the end of the year, causing alarm among doctors and pharmacists.

US pharmaceutical company Indivior confirmed the marketing and sale of the long-acting injectable prescription opioid Sublocade would end from 31 December, with a company spokesperson describing it as a “commercial decision”.